Get Live Data

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Avacta Group Share Price
  4. Avacta Group Share Regulatory News
  5. Issue of Equity

Pin to quick picksAvacta Group Regulatory News (AVCT)

Avacta Group Information

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
69.50    -1.00 (-1.42%)
Bid:
69.00
Ask:
70.00
Spread: 1.00 (1.449%)
Market Cap: £325.64m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Issue of Equity

10 Jul 2009 16:17

RNS Number : 5118V
Avacta Group PLC
10 July 2009
 



Avacta Group plc

Issue of Equity

Avacta Group plc (the "Company") announces that 750,700 ordinary shares of 0.1p each ("Ordinary Shares")  have been issued at an average price of 1.93 pence per share pursuant to contractual obligations  for services provided to the Company. 

Application has been made for 750,700 new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 17 July 2009.

The total number of Ordinary Shares in issue following the above issue will be 1,152,502,071.

Enquiries:

Avacta Group plc
Tim Sykes, Chief Financial Officer
 
Tel: 087 0835 4367
Daniel Stewart & Company Plc
Simon Leathers/Charlotte Stranner
 
Tel: 020 7776 6550
Novum Securities Limited
Henry Turcan
 
Tel: 020 7562 4700

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEURAVRKORBAAR
12345678910
Date   Source Headline
6th Apr 20237:00 amRNS1st US Clinical Investigator AVA6000 Sites Opened
5th Apr 20237:00 amRNSFirst Patient Dosed in Fifth Cohort of AVA6000
3rd Apr 20237:00 amRNSNotice of Results and Investor Presentation
27th Mar 20237:00 amRNSAVA3996 data poster presentation at AACR
13th Mar 20237:00 amRNSStatement re: Silicon Valley Bank
23rd Feb 20237:00 amRNSAvacta Therapeutics Division Science Day
13th Feb 20237:00 amRNSIssue of Equity and Total Voting Rights
23rd Jan 202312:20 pmRNSIssue of Equity and Total Voting Rights
17th Jan 20232:05 pmRNSSecond Price Monitoring Extn
17th Jan 20232:00 pmRNSPrice Monitoring Extension
17th Jan 202311:05 amRNSSecond Price Monitoring Extn
17th Jan 202311:00 amRNSPrice Monitoring Extension
17th Jan 20239:05 amRNSSecond Price Monitoring Extn
17th Jan 20239:00 amRNSPrice Monitoring Extension
17th Jan 20237:00 amRNSSuccessful Completion of Fourth Dose Escalation
16th Jan 202310:15 amRNSBlock Listing Application to AIM
19th Dec 20227:00 amRNSAvacta to Host Therapeutics Division Science Day
8th Nov 20227:01 amRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSResult of the Open Offer
31st Oct 20221:32 pmRNSAvacta to Present at Theranostics FAP Summit
31st Oct 202211:05 amRNSSecond Price Monitoring Extn
31st Oct 202211:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSBlock Listing Six Monthly Return
20th Oct 20228:01 amRNSDirector/PDMR Shareholding
20th Oct 20228:01 amRNSAdmission of the Company’s Ordinary Shares
20th Oct 20227:00 amRNSPosting of the Company’s Open Offer Circular
18th Oct 202211:49 amRNSResult of Placing
18th Oct 20229:16 amRNSPrivate CB and ABB Launch
18th Oct 20229:14 amRNSProposed acquisition of Launch Diagnostics
29th Sep 20227:00 amRNSInterim Results for the Period Ended 30 June 2022
26th Sep 20227:00 amRNSNotice of Results
5th Sep 20227:00 amRNSAVA6000 receives Orphan Drug Designation from FDA
1st Sep 20227:00 amRNSPhase I study of AVA6000 advances to fourth cohort
21st Jul 20227:00 amRNSAffyXell successfully completes funding round
30th Jun 20227:00 amRNSLG Chem renews license triggers payment to Avacta
29th Jun 20229:05 amRNSSecond Price Monitoring Extn
29th Jun 20229:00 amRNSPrice Monitoring Extension
29th Jun 20227:00 amRNSSecond dose escalation in phase 1 trial of AVA6000
23rd Jun 20224:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20224:36 pmRNSPrice Monitoring Extension
23rd Jun 20224:27 pmRNSResult of Annual General Meeting
16th Jun 20224:41 pmRNSSecond Price Monitoring Extn
16th Jun 20224:36 pmRNSPrice Monitoring Extension
31st May 20227:00 amRNSPosting of Annual Report and Notice of AGM
16th May 202212:00 pmRNSAffyXell expands partnership with GenScript ProBio
11th May 20227:00 amRNSLondon Therapeutics headquarters established
6th May 20227:00 amRNSBlock Listing Application to AIM (update)
28th Apr 20221:53 pmRNSBlock Listing Application to AIM
14th Apr 20225:01 pmRNSIssue of Equity and Total Voting Rights
14th Apr 202211:29 amRNSIssue of Equity and Total Voting Rights
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
JETG
JETG.L
LSE
0.00%
0A1K
Nio Ads Rep 1 C
LSE
0.00%
INL
INL.L
LSE
0.00%
BRLA
Blackrock Lat A
LSE
1.70%
MSLH
Marshalls
LSE
-5.15%
Trending
GGP
Greatland Resources
LSE
-6.98%
CPI
Capita
LSE
-0.89%
PREM
Premier African Minerals
LSE
3.03%
GST
GSTechnologies
LSE
0.00%
AVCT
Avacta Group
LSE
-1.42%